Log in

The Gastro Girl Podcast - Managing Barrett's Esophagus: Treatments & Risk Reduction
share icon

Managing Barrett's Esophagus: Treatments & Risk Reduction

The Gastro Girl Podcast

06/10/25

28m

About

Comments

Featured In

In Part 3 of our 4-part series on GERD and Barrett's Esophagus, we're joined by Dr. Caitlin Houghton, a foregut surgeon with Keck Medicine of USC, to discuss what happens after Barrett's Esophagus is diagnosed—and how patients can reduce their cancer risk and manage the condition effectively.

From reflux control to endoscopic eradication therapy (EET), and in some cases, surgery, Dr. Houghton breaks down the latest treatment strategies and what patients need to know. This episode offers practical advice, expert insights, and real hope for those navigating life with Barrett's.

Topics include:

  • What Barrett's Esophagus is and why it matters
  • How doctors decide when and how to treat
  • The role of EET, medications, and lifestyle changes
  • When surgery may be necessary
  • Tips for patients to advocate for their care

Missed the earlier episodes? Catch up here: Part 1 – From Reflux to Risk: How Heartburn and GERD Could Lead to Esophageal Cancer https://gastrogirl.com/podcast/from-reflux-to-risk-how-heartburn-and-gerd-could-lead-to-esophageal-cancer/

Part 2 – Barrett's Esophagus: The Hidden Risk of Chronic Heartburn https://gastrogirl.com/podcast/barretts-esophagus-the-hidden-risk-of-chronic-heartburn/

This series is sponsored by Castle Biosciences and produced in collaboration with leading clinicians and researchers committed to improving patient outcomes.

Previous Episode

In part 2 of our 4-part series on GERD and Barrett's Esophagus, we take a closer look at what Barrett's esophagus is, how it develops from chronic acid reflux, and why early detection is essential to reducing the risk of esophageal cancer.

We're joined by Dr. Raman Muthusamy, a nationally recognized expert in gastroenterology and advanced endoscopy, who explains how Barrett's is diagnosed, the latest tools and technologies involved, and how a team-based approach improves outcomes.

If you or someone you care about struggles with long-term heartburn or GERD, this episode offers critical insights to help you take action before it becomes something more serious.

Missed Part 1? Listen or watch now:From Reflux to Risk: How Heartburn and GERD Could Lead to Esophageal Cancer https://bit.ly/3Fvzf4o

This series is sponsored by Castle Biosciences and produced in collaboration with leading clinicians and researchers dedicated to improving patient care and outcomes.

Next Episode

In the final episode of our 4-part series on GERD and Barrett's Esophagus, we move beyond awareness to focus on action. What should patients actually do after diagnosis—and how can they take charge of their care journey?

We're joined by Tedra Gray, a seasoned Advanced Practice Provider, who shares real-world examples and practical advice for patients navigating chronic reflux, Barrett's Esophagus, or treatment follow-up.

You'll learn:

  • Why early diagnosis and follow-up matter
  • What can happen if Barrett's Esophagus is left untreated
  • How shared decision-making helps build the right care plan
  • The different approaches for patients at low, moderate, or high risk

Whether you're newly diagnosed or managing long-term reflux, this episode offers compassionate, expert-backed guidance to help you feel informed and empowered.

Missed the earlier episodes? Catch up here: Part 1 – From Reflux to Risk: How Heartburn and GERD Could Lead to Esophageal Cancer https://gastrogirl.com/podcast/from-reflux-to-risk-how-heartburn-and-gerd-could-lead-to-esophageal-cancer/

Part 2 – Barrett's Esophagus: The Hidden Risk of Chronic Heartburn https://gastrogirl.com/podcast/barretts-esophagus-the-hidden-risk-of-chronic-heartburn/

Part 3 – Managing Barrett's Esophagus: Treatments and Risk Reduction https://gastrogirl.com/podcast/managing-barretts-esophagus-treatments-risk-reduction/

This series is sponsored by Castle Biosciences and produced in collaboration with leading clinicians and researchers committed to improving patient outcomes.

Promoted